首页> 美国卫生研究院文献>Nature Communications >Increased yields and biological potency of knob-into-hole-based soluble MHC class II molecules
【2h】

Increased yields and biological potency of knob-into-hole-based soluble MHC class II molecules

机译:基于孔入孔的可溶性MHC II类分子的产量提高和生物学效力提高

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Assembly of soluble peptide-major histocompatibility complex class II (pMHCII) monomers into multimeric structures enables the detection of antigen-specific CD4+ T cells in biological samples and, in some configurations, their reprogramming in vivo. Unfortunately, current MHCII-αβ chain heterodimerization strategies are typically associated with low production yields and require the use of foreign affinity tags for purification, precluding therapeutic applications in humans. Here, we show that fusion of peptide-tethered or empty MHCII-αβ chains to the IgG1-Fc mutated to form knob-into-hole structures results in the assembly of highly stable pMHCII monomers. This design enables the expression and rapid purification of challenging pMHCII types at high yields without the need for leucine zippers and purification affinity tags. Importantly, this design increases the antigen-receptor signaling potency of multimerized derivatives useful for therapeutic applications and facilitates the detection and amplification of low-avidity T cell specificities in biological samples using flow cytometry.
机译:将可溶性肽-主要组织相容性复合物II类(pMHCII)单体组装成多聚体结构,可以检测生物样品中的抗原特异性CD4 + T细胞,并且在某些配置下还可以对其进行体内重编程。不幸的是,当前的MHCII-αβ链异二聚化策略通常与低产率相关,并且需要使用外来亲和标签进行纯化,从而排除了在人类中的治疗应用。在这里,我们显示肽拴或空的MHCII-αβ链与突变的IgG1-Fc形成结入孔结构的融合导致了高度稳定的pMHCII单体的组装。该设计无需高亮氨酸拉链和纯化亲和标签,就可以高产量表达和快速纯化具有挑战性的pMHCII类型。重要的是,该设计提高了可用于治疗应用的多聚衍生物的抗原受体信号传导能力,并有助于使用流式细胞仪检测和扩增生物样品中的低度T细胞特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号